Lead compound · MOTS-c
In short: ClearCost Wellness previews four planned laboratory research peptides: MOTS-c, GLOW Blend, KLOW Blend, and Semax (10 mg vial). Launch prices publish here when the store opens. Everything is intended for laboratory research use only and is not FDA-approved.
MOTS-c is a small peptide encoded in mitochondrial DNA and one of the most studied compounds in longevity research. In July 2026 the FDA's Pharmacy Compounding Advisory Committee voted 7-5-2 to recommend it for the federal 503A compounding bulks list; FDA staff recommended against it at the same meeting, the committee's vote is advisory only, and it is not approval. Final rulemaking is still pending. The pricing story is just as striking: across 17 tracked retail offers, the lowest 10 mg listing was $18.95 (PeptidePrices, checked 24 October 2026), with a wide spread between vendors. That spread is why this store exists.
| Lowest tracked 10mg listing | $18.95 |
| Vendors tracked | 252 (169 with issuer-verified COAs) |
| ClearCost Wellness launch price | Publishes at launch |
Source: PeptidePrices vendor tracking, checked 24 October 2026. Tracked listings are not like-for-like: testing, documentation and discounts differ between vendors, so the lowest listing is not proof of equivalent product. Launch prices publish when the store opens.
Four planned research materials. No prices are published yet; they publish at launch. Batch documentation requirements are still being verified with suppliers and publish before ordering opens. Intended strictly for in-vitro laboratory research.
A 16-amino-acid peptide encoded in mitochondrial DNA, studied in metabolic and exercise-response models. Advisory committee vote 7-5-2 in July 2026, against FDA staff opposition; advisory only, not approval.
Lowest tracked 10mg listing: $18.95 across 17 offers (PeptidePrices, 24 Oct 2026)
Preview — ordering opens at launch.
BPC-157, TB-500, and GHK-Cu in one vial, the combination researchers often study together.
Blend vials are not tracked by major price indexes; compare component prices on the research pages.
Preview — ordering opens at launch.
Everything in GLOW, plus KPV — a tripeptide most suppliers can't sell you on its own. KPV was recommended by the advisory committee in July 2026 (vote 8-6-1), against FDA staff opposition; advisory only, not approval.
Blend vials are not tracked by major price indexes; compare component prices on the research pages.
Preview — ordering opens at launch.
A cognitive-research peptide planned here as a 10 mg lyophilized vial for laboratory research. It drew the joint-strongest advisory committee vote in its class (8-5-1, July 2026), against FDA staff opposition; advisory only, not approval.
Lowest tracked 10mg listing: $17.84 across 20 offers (PeptidePrices, 24 Oct 2026)
Preview — ordering opens at launch.
Research-channel retail prices for the same catalogue item often run two to three times apart between vendors, and trade-level prices sit far below retail. That spread pays for testing, warehousing, and fulfillment, and at many stores it also pays for the hope that you never check. We publish the check.
The wholesale benchmark and the market median (or range), with sources and dates, on every product page. Even the pages where our price isn't the lowest.
Every product page states what the research actually shows and where it is thin. Early-stage means early-stage. No outcome claims, ever.
We intend to publish a certificate of analysis for each batch. That requirement is still being verified with suppliers and will be confirmed before ordering opens. If a store cannot show you one, walk away.
Our store is in preview with four planned products. For compounds outside our planned catalog, our affiliate partner, Bench Grade Peptides, is open today.
Shop the wider catalog at Bench Grade
Affiliate link — we may earn a commission at no additional cost to you. Research use only.